# Ribopeutic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ribopeutic

- Industry: Pharmaceuticals
- Headquarters: Hangzhou, China
- Latest round: Series A (Mar 17, 2025)
- Investors on record: 3

## About

Established in 2022 and based in Hangzhou, China, Ribopeutic is a biomedical service provider that provides small molecule drugs targeting RNA. In March 2025, it closed a series A funding from new investor Heda Venture.

The company's main business is the development of small molecule drugs targeting RNA.


The company generates revenue by providing small molecule drugs targeting RNA.

## Funding rounds

- Series A, Mar 17, 2025 — Heda Venture
- Angel, Jun 29, 2023 — Sinovation Ventures, HSG

## Investors

- Sinovation Ventures (https://capitalatlas.ai/funds/sinovation-ventures) — Angel
- HSG (https://capitalatlas.ai/funds/hsg) — Angel
- Heda Venture (https://capitalatlas.ai/funds/heda-venture) — Series A